Literature DB >> 25593326

Mycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR-dependent manner.

Pawan Kumar1, Vini John1, Soumitra Marathe1, Gobardhan Das1, Sangeeta Bhaskar2.   

Abstract

MIP is a nonpathogenic, soil-borne predecessor of Mycobacterium avium. It has been reported previously that MIP possesses strong immunomodulatory properties and confers protection against experimental TB and tumor. DCs, by virtue of their unmatched antigen-presentation potential, play a critical role in activation of antitumor and antimycobacterial immune response. The effect of MIP on the behavior of DCs and the underlying mechanisms, however, have not been investigated so far. In the present study, we showed that MIP induces significant secretion of IL-6, IL-12p40, IL-10, and TNF-α by DCs and up-regulates the expression of costimulatory molecules CD40, CD80, and CD86. MIP(L) induced a significantly higher response compared with MIP(K). PI and Annexin V staining showed that MIP increases DC survival by inhibiting apoptosis. Consistently, higher expression of antiapoptotic proteins Bcl-2 and Bcl-xl was observed in MIP-stimulated DCs. Cytokines, produced by naïve T cells, cocultured with MIP-stimulated DCs, showed that MIP promotes Th1/Th17 polarization potential in DCs. Response to MIP was lost in MyD88(-/-)DCs, underscoring the critical role of TLRs in MIP-induced DC activation. Further studies revealed that TLR2 and TLR9 are involved in DC activation by MIP(L), whereas MIP(K) activates the DCs through TLR2. Our findings establish the DC activation by MIP, define the behavior of MIP-stimulated DCs, and highlight the role of TLRs in MIP-induced DC activation. © Society for Leukocyte Biology.

Entities:  

Keywords:  T cell polarization; apoptosis; costimulatory molecules; cytokines; pattern recognition receptors

Mesh:

Substances:

Year:  2015        PMID: 25593326      PMCID: PMC5477886          DOI: 10.1189/jlb.1A0714-361R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  37 in total

Review 1.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 2.  Innate immunity: impact on the adaptive immune response.

Authors:  R Medzhitov; C A Janeway
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

3.  BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro.

Authors:  Jeppe Madura Larsen; Christine Stabell Benn; Yvonne Fillie; Desiree van der Kleij; Peter Aaby; Maria Yazdanbakhsh
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

4.  Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion.

Authors:  Adnan M Al-Ayoubi; Hui Zheng; Yuying Liu; Tao Bai; Scott T Eblen
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

5.  Tumor-associated dendritic cells: molecular mechanisms to suppress antitumor immunity.

Authors:  Yoshihiko Hirohashi; Noriyuki Sato
Journal:  Immunotherapy       Date:  2011-08       Impact factor: 4.196

6.  Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production.

Authors:  Caroline Demangel; Patrick Bertolino; Warwick J Britton
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

Review 7.  Tumor-host immune interactions and dendritic cell dysfunction.

Authors:  Li Yang; David P Carbone
Journal:  Adv Cancer Res       Date:  2004       Impact factor: 6.242

Review 8.  Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism.

Authors:  Vojo Deretic; Sudha Singh; Sharon Master; James Harris; Esteban Roberts; George Kyei; Alex Davis; Sergio de Haro; John Naylor; Huang-Ho Lee; Isabelle Vergne
Journal:  Cell Microbiol       Date:  2006-05       Impact factor: 3.715

9.  TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Authors:  B R Wong; R Josien; S Y Lee; B Sauter; H L Li; R M Steinman; Y Choi
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

10.  Mycobacteria target DC-SIGN to suppress dendritic cell function.

Authors:  Teunis B H Geijtenbeek; Sandra J Van Vliet; Estella A Koppel; Marta Sanchez-Hernandez; Christine M J E Vandenbroucke-Grauls; Ben Appelmelk; Yvette Van Kooyk
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  6 in total

1.  Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism.

Authors:  Hui-Ming Chen; Linus Sun; Ping-Ying Pan; Lu-Hai Wang; Shu-Hsia Chen
Journal:  Cancer Immunol Immunother       Date:  2021-04-20       Impact factor: 6.968

Review 2.  Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression.

Authors:  Eileena F Giurini; Mary Beth Madonna; Andrew Zloza; Kajal H Gupta
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

3.  Enhanced survival of BCG-stimulated dendritic cells: involvement of anti-apoptotic proteins and NF-κB.

Authors:  Pawan Kumar; Vini John; Ananya Gupta; Sangeeta Bhaskar
Journal:  Biol Open       Date:  2018-06-20       Impact factor: 2.422

4.  Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner.

Authors:  Pawan Kumar; Gobardhan Das; Sangeeta Bhaskar
Journal:  BMC Res Notes       Date:  2019-10-07

5.  Cytokine Storm and Immunomodulation in COVID-19.

Authors:  Pradeep Rangappa
Journal:  Indian J Crit Care Med       Date:  2021-11

Review 6.  Survivin: a unique target for tumor therapy.

Authors:  Himani Garg; Prerna Suri; Jagdish C Gupta; G P Talwar; Shweta Dubey
Journal:  Cancer Cell Int       Date:  2016-06-23       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.